Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P van Meerbeeck

Showing results (211-220 of 250) with videos related to

Pageof 25
Sort By:
Translational Lung Cancer Research|March 26, 2015
ALK and crizotinib: after the honeymoon…what else? Resistance mechanisms and new therapies to overcome itChristian Rolfo, Francesco Passiglia, Marta Castiglia, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 28, 2016
The IASLC Mesothelioma Staging Project: Improving Staging of a Rare Disease Through International ParticipationHarvey Pass, Dorothy Giroux, Catherine Kennedy, et al.
Lung Cancer (Amsterdam, Netherlands)|June 9, 2015
Rehabilitation in patients with radically treated respiratory cancer: A randomised controlled trial comparing two training modalitiesBihiyga Salhi, Christel Haenebalcke, Silvia Perez-Bogerd, et al.
The Lancet. Oncology|February 1, 2014
Health-related quality of life in small-cell lung cancer: a systematic review on reporting of methods and clinical issues in randomised controlled trialsEfstathios Zikos, Irina Ghislain, Corneel Coens, et al.
The Lancet. Oncology|October 20, 2019
Tumour Treating Fields in combination with pemetrexed and cisplatin or carboplatin as first-line treatment for unresectable malignant pleural mesothelioma (STELLAR): a multicentre, single-arm phase 2 trialGiovanni L Ceresoli, Joachim G Aerts, Rafal Dziadziuszko, et al.
European Journal of Cancer (Oxford, England : 1990)|June 21, 2006
Quality assurance of thoracic radiotherapy in EORTC 08941: a randomised trial of surgery versus thoracic radiotherapy in patients with stage IIIA non-small-cell lung cancer (NSCLC) after response to induction chemotherapyGijsbert W P M Kramer, Catherine L Legrand, Paul van Schil, et al.
Lung Cancer (Amsterdam, Netherlands)|December 18, 2004
Improving the specificity of fluorescence bronchoscopy for the analysis of neoplastic lesions of the bronchial tree by combination with optical spectroscopy: preliminary communicationMartin P L Bard, Arjen Amelink, Marina Skurichina, et al.
Plos One|June 11, 2021
Epidermal growth factor as a potential prognostic and predictive biomarker of response to platinum-based chemotherapyMargot Geens, Sofie Stappers, Heleen Konings, et al.
British Journal of Cancer|March 5, 2002
Multicentre phase II study of gemcitabine and cisplatin in malignant pleural mesotheliomaJ M W van Haarst, P Baas, Ch Manegold, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 28, 2002
Standard versus intensified chemotherapy with granulocyte colony-stimulating factor support in small-cell lung cancer: a prospective European Organization for Research and Treatment of Cancer-Lung Cancer Group Phase III Trial-08923Andrea Ardizzoni, Vivianne C G Tjan-Heijnen, Pieter E Postmus, et al.
Pageof 25

Showing results (211-220 of 250) with videos related to

Sort By:
Pageof 25
Translational Lung Cancer Research|March 26, 2015
ALK and crizotinib: after the honeymoon…what else? Resistance mechanisms and new therapies to overcome itChristian Rolfo, Francesco Passiglia, Marta Castiglia, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 28, 2016
The IASLC Mesothelioma Staging Project: Improving Staging of a Rare Disease Through International ParticipationHarvey Pass, Dorothy Giroux, Catherine Kennedy, et al.
Lung Cancer (Amsterdam, Netherlands)|June 9, 2015
Rehabilitation in patients with radically treated respiratory cancer: A randomised controlled trial comparing two training modalitiesBihiyga Salhi, Christel Haenebalcke, Silvia Perez-Bogerd, et al.
The Lancet. Oncology|February 1, 2014
Health-related quality of life in small-cell lung cancer: a systematic review on reporting of methods and clinical issues in randomised controlled trialsEfstathios Zikos, Irina Ghislain, Corneel Coens, et al.
The Lancet. Oncology|October 20, 2019
Tumour Treating Fields in combination with pemetrexed and cisplatin or carboplatin as first-line treatment for unresectable malignant pleural mesothelioma (STELLAR): a multicentre, single-arm phase 2 trialGiovanni L Ceresoli, Joachim G Aerts, Rafal Dziadziuszko, et al.
European Journal of Cancer (Oxford, England : 1990)|June 21, 2006
Quality assurance of thoracic radiotherapy in EORTC 08941: a randomised trial of surgery versus thoracic radiotherapy in patients with stage IIIA non-small-cell lung cancer (NSCLC) after response to induction chemotherapyGijsbert W P M Kramer, Catherine L Legrand, Paul van Schil, et al.
Lung Cancer (Amsterdam, Netherlands)|December 18, 2004
Improving the specificity of fluorescence bronchoscopy for the analysis of neoplastic lesions of the bronchial tree by combination with optical spectroscopy: preliminary communicationMartin P L Bard, Arjen Amelink, Marina Skurichina, et al.
Plos One|June 11, 2021
Epidermal growth factor as a potential prognostic and predictive biomarker of response to platinum-based chemotherapyMargot Geens, Sofie Stappers, Heleen Konings, et al.
British Journal of Cancer|March 5, 2002
Multicentre phase II study of gemcitabine and cisplatin in malignant pleural mesotheliomaJ M W van Haarst, P Baas, Ch Manegold, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 28, 2002
Standard versus intensified chemotherapy with granulocyte colony-stimulating factor support in small-cell lung cancer: a prospective European Organization for Research and Treatment of Cancer-Lung Cancer Group Phase III Trial-08923Andrea Ardizzoni, Vivianne C G Tjan-Heijnen, Pieter E Postmus, et al.
Pageof 25